Longevity & AgingAllen Institute Launches $400M Initiative to Map the Aging Brain Cell by Cell
The Allen Institute's Brain Health Accelerator is a $400 million collaboration among roughly 30 organizations aiming to understand why the aging brain breaks down. Instead of chasing single proteins like amyloid or tau — approaches that have repeatedly disappointed — the initiative maps which specific cell types and circuits become vulnerable first. Crucially, it starts with real human brain tissue rather than animal models, hoping to avoid the translation failures that have plagued the field. Alzheimer's, Parkinson's, Huntington's, Lewy body dementia and ALS are studied side by side, with shared data infrastructure and AI tools, in hopes of revealing common biological threads hiding across these diseases.
